Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Filer

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
Nature Communications|April 21, 2021
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritisYilin Wang, Aneesah Khan, Aristotelis Antonopoulos, et al.
Arthritis Research & Therapy|November 20, 2016
Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilageAdam P Croft, Amy J Naylor, Jennifer L Marshall, et al.
Cell Reports|November 7, 2014
Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in miceAlexander V Misharin, Carla M Cuda, Rana Saber, et al.
Plos One|August 10, 2017
Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritisIvy Y Choi, Olga N Karpus, Jason D Turner, et al.
The Journal of Pathology|September 1, 2016
11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammationRowan S Hardy, Craig L Doig, Zahrah Hussain, et al.
Arthritis and Rheumatism|May 30, 2009
Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathwaysAndrew Filer, Magdalena Bik, Greg N Parsonage, et al.
Skeletal Muscle|December 13, 2021
Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort studyAmritpal Dhaliwal, Felicity R Williams, Jonathan I Quinlan, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Genome Biology|August 26, 2021
Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritabilityXiangyu Ge, Mojca Frank-Bertoncelj, Kerstin Klein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial FluidJulia Spengler, Božo Lugonja, A Jimmy Ytterberg, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Nature Communications|April 21, 2021
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritisYilin Wang, Aneesah Khan, Aristotelis Antonopoulos, et al.
Arthritis Research & Therapy|November 20, 2016
Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilageAdam P Croft, Amy J Naylor, Jennifer L Marshall, et al.
Cell Reports|November 7, 2014
Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in miceAlexander V Misharin, Carla M Cuda, Rana Saber, et al.
Plos One|August 10, 2017
Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritisIvy Y Choi, Olga N Karpus, Jason D Turner, et al.
The Journal of Pathology|September 1, 2016
11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammationRowan S Hardy, Craig L Doig, Zahrah Hussain, et al.
Arthritis and Rheumatism|May 30, 2009
Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathwaysAndrew Filer, Magdalena Bik, Greg N Parsonage, et al.
Skeletal Muscle|December 13, 2021
Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort studyAmritpal Dhaliwal, Felicity R Williams, Jonathan I Quinlan, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Genome Biology|August 26, 2021
Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritabilityXiangyu Ge, Mojca Frank-Bertoncelj, Kerstin Klein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial FluidJulia Spengler, Božo Lugonja, A Jimmy Ytterberg, et al.
Pageof 17